“Chinese oncologists at Sichuan University were the first in the world to insert CRISPR-modified cells into a patient suffering from an aggressive form of lung cancer, according to Nature. The journal reports that this first round of treatment in a
“Regenerative medicine investigators at the Cedars-Sinai Medical Center have received U.S. Food and Drug Administration (FDA) approval to test a novel combination stem cell-gene therapy they’ve developed to stall amyotrophic lateral sclerosis (ALS) progression. Enrollment in the trial is expected
From the BBC: “Madeleine’s team is at work on a task so absurd it seems more wizardly than scientific: they’re transforming human skin into brains. “The brains develop in the same way you would see in an embryo,” says Madeleine.
“Good news for people with type 1 diabetes. The first “artificial pancreas” has been approved by the U.S. Food and Drug Administration (FDA). Innovative medical technology company Medtronic’s MiniMed 670G is the first device to combine an automated glucose monitor
A great advance: “Now, Ramille Shah at Northwestern University in Evanston, Illinois, and her colleagues have developed an ink that can be 3D-printed into bone implants that are robust but ultra-elastic, allowing surgeons to cut and manipulate them in the
From PopSci: Recently,”pharmaceutical giant GlaxoSmithKline announced a partnership with Google’s Verily (formerly Google Life Sciences) to create effective bioelectronic devices to treat chronic conditions such as diabetes, arthritis, and inflammatory bowel diseases. “Bioelectronics are small devices that are implanted into
“Arthritis sufferers have been offered new hope after scientists grew a ‘living hip’ in the lab which not only replaces worn cartilage but stops painful joints returning. Researchers in the US have used stem cells to grow cartilage in the
I’ll be moderating a longevity panel tomorrow at VLAB. VLAB is the San Francisco Bay Area chapter of the MIT Enterprise Forum, a global non-profit organization dedicated to connecting Silicon Valley’s entrepreneurs, industry experts, venture capitalists, private investors and technologists
From MIT Tech Review: “The treatment is different than any that’s come before because it appears to be an outright cure carried out through a genetic repair. The therapy was tested on 18 children, the first of them 15 years
Another great article by the WAPO’s Ariana Eunjug Cha. Here’s a small excerpt from the piece: “As a tidal wave of new health-related gadgets, apps and tests hits the market, government agencies like the FDA, Federal Trade Commission and others
From the Washington Post. “Scientists reported Tuesday on two new studies showing that the medications, which marshal the body’s own immune defenses, are now proving effective against recurrent, difficult-to-treat head and neck cancer and an extremely lethal skin cancer called
Here’s some interesting news from The Scripps Research Institute (TSRI) and the Mayo Clinic. Researchers found that a combination of two drugs — cancer drug dasatinib and quercetin — “dramatically slows the aging process (in animal models)—alleviating symptoms of frailty,
A new study shows that, for a small number of lucky individuals, it is possible to have a faulty gene that causes severe disease and not get that disease (think cystic fibrosis, etc). The problem though is that researchers don’t
From the Telegraph: “Researchers from Orlando Health in Florida detected a biomarker released by the brain during injury. They found that the biomarker can stay in the bloodstream for up to a week – which means patients who suffer delayed
The idea behind the company is to expel toxic, worn-out cells called “senescent cells.” Here’s the story in Fortune.
Remember the horrific Thalidomide disaster when babies were being born without limbs? Well, turns out the drug might have a happier purpose. Researchers have figured out how to use it to bioengineer a way to kill cancer. Here’s the story.
From TechCrunch: “From Google[x]’s cancer-seeking nanopills to Atomwise, a machine-learning platform working on finding the cure to orphan diseases, the Bay Area offers several startups and organizations coming at the problem in a different way.Incubators such as Y Combinator, IndieBio
From New Scientist: “One-year-old Layla was dying from leukaemia after all conventional treatments failed. “We didn’t want to give up on our daughter, though, so we asked the doctors to try anything,” her mother Lisa said in a statement released
From ScienceMag.org: “Harvard stem cell biologist Amy Wagers, cardiologist Richard Lee of the Harvard-affiliated Brigham and Women’s Hospital in Boston, and their colleagues claim that a specific protein, GDF11, may explain young blood’s beneficial effects. They have reported that blood
According to Nature, researchers are poised to meet with the FDA this month to discuss “medicines that delay ageing-related disease as legitimate drugs.” This makes sense, given that there are a number of scientific teams working on such compounds. Nir